Cynthia M. Butitta
Chief Financial Officer, MABVAX THERAPEUTICS HOLDINGS, INC.
Companies
- Autolus TherapeuticsBoard member Mar 18, 2026 to now1
- Century Therapeutics (United States)Board member Jun 17, 2021 to now2
- Olema Pharmaceuticals, Inc.Board member Nov 18, 2020 to now3
- UroGen Pharma Ltd.Board member Jan 10, 2019 to now4
- Kite PharmaChief operating officer Jun 19, 2014 to Oct 5, 20175
- Kite PharmaChief financial officer Jun 19, 2014 to Apr 6, 20165
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- UroGen Pharma Ltd. URGN2,000 shares6$68.4K at $34.19Nov 26, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 26, 2025Exercised options 2,000 shares of UroGen Pharma Ltd.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAutolus Therapeutics, Board member
- 2
- 3
- 4SEC EDGARUroGen Pharma Ltd., Board member
- 5SEC EDGARKite Pharma, Chief operating officer
- 6